The Lancet. Infectious diseases
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial.
Ilse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, Chiara Fineschi, Elisa Marchetti, Rita La Gaetana, Simona Nigro, Martina Carducci, Luisa Massai, Valentino Conti, Omar Rossi, Giulia Luna Cilio, Alimamy Serry-Bangura, Pietro Tessitore, Pierre Van Damme
Published: 202610.1016/S1473-3099(25)00730-3
Abstract
BACKGROUND: Enteric fever caused by Salmonella enterica serovars Typhi and Paratyphi A remains a major concern. No vaccines are licensed against Salmonella Paratyphi A. We aimed to assess the safety and immunogenicity of an investigational conjugate…
Preview only. Read the full abstract at the source